Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Market watchers are predicting strong performance driven by the robust sales of Lilly's blockbuster medications, particularly recent launches. However, there are also concerns about potential pressure